Kedrion S.p.A

In News

Inforegio - Developing orphan drugs for orphan diseases in Tuscany, Italy - European Commission

European Commission - Jul 18, 2026

US Immunoglobulin Market Size, Share | Industry Report [2034] - Fortune Business Insights

Fortune Business Insights - Aug 03, 2026

FDA Approves 10% IVIG Formulation For Adults With Primary Humoral Immunodeficiency - Pharmacy Times

Pharmacy Times - Sep 29, 2025

Kedrion Names Val Romberg As CEO - PR Newswire

PR Newswire - Oct 06, 2020

Kedrion S.p.A. -- Moody's assigns first-time B1 rating to Kedrion; outlook stable - Yahoo Finance

Yahoo Finance - Apr 26, 2021

Emiliano Ranati - Acea

Acea - Feb 06, 2026

It’s official, Permira strikes control of leading plasma derivatives maker Kedrion and British competitor BPL. Together with ADIA. The Marcucci family and FSI fund to reinvest in the deal. Cdp Equity takes a call option – BeBeez International - BeBeez International

BeBeez International - Jan 21, 2022

New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia | Communications Biology - Nature

Nature - Jan 30, 2024

Kedrion reports a 15% Ebitda on €660.4m of revenues in 2021 - PR Newswire

PR Newswire - Apr 11, 2022

KEDPLASMA USA Expanding with Two More Plasma Collection Centers; Ongoing Growth Continues to Benefit Rare Disease Patients - BioSpace

BioSpace - Jul 24, 2018

Plasminogen, human-tvmh for the treatment of children and adults with plasminogen deficiency type 1 - Wiley Online Library

Wiley Online Library - Sep 06, 2023

Kedrion Biopharma closes 2024 with a growth of +10% and unveils its new identity - Yahoo Finance

Yahoo Finance - Apr 14, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment